News >

Precision Medicine a Necessary Component in HER2+ Breast Cancer Care

Danielle Bucco
Published: Monday, Dec 18, 2017

Dr Mothaffar F. Rimawi

Mothaffar F. Rimawi, MD
Precision medicine has become essential in delivering optimal and individualized care for patients with HER2-positive breast cancer.

Rimawi, associate professor, Baylor College of Medicine, medical director and director of clinical research at Baylor's Lester and Sue Smith Breast Center and the Smith Clinic/ Ben Taub Hospital, and co-leader of the breast program at Baylor's Dan L. Duncan Cancer Center, discussed the significance of precision medicine in HER2-positive breast cancer, as well as the possible role of immunotherapy for this specific population.

OncLive: What is the importance of precision medicine in HER2-positive breast cancer?

Rimawi: [At SABCS] I discussed the research that is shedding light on HER2-positive breast cancer, including mechanisms of resistance, sensitivity, and the efforts to tailor treatments to the individual patient.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Community Practice Connections™: Evolving Applications for PARP Inhibitors in Ovarian Cancer: Building on a Solid FoundationAug 15, 20191.5
Publication Bottom Border
Border Publication
x